Company / FCF Margin
Decoy Therapeutics Inc. FCF Margin History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-197.1%
FY2021
5-year range
-3226.7% / -197.1%
FY2018-FY2021
Trend
+41.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -3226.7% to -197.1% over the past 3 years.
Based on SEC 10-K filings.
-197.1% in FY2021.
Improved from -3226.7% to -197.1% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +3029.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, fcf margin increased 41.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | -197.1% | +41.0% |
| FY2020 | -334.2% | - |
| FY2019 | - | - |
| FY2018 | -3226.7% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026